한글목차

세계의 트랜스펙션 시약과 장비 시장은 2030년까지 18억 달러에 달할 전망

2023년에 12억 달러로 추정된 세계의 트랜스펙션 시약과 장비 시장은 2030년에는 18억 달러에 달하며, 분석 기간인 2023-2030년 CAGR은 6.1%로 성장할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 트랜스펙션 시약은 CAGR 6.6%를 기록하며, 분석 기간 종료까지 12억 달러에 달할 것으로 예측됩니다. 트랜스펙션 장비 부문의 성장률은 분석 기간 중 CAGR 5.3%로 추정됩니다.

미국 시장은 3억 2,410만 달러로 추정, 중국은 CAGR 5.7%로 성장 예측

미국의 트랜스펙션 시약과 장비 시장은 2023년에 3억 2,410만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은2023-2030년 CAGR을 5.7%로, 2030년까지 2억 8,270만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 5.3%와 5.2%로 예측됩니다. 유럽에서는 독일이 CAGR 4.7%로 성장할 것으로 예측됩니다.

세계의 트랜스펙션 시약과 장비 시장 - 주요 동향과 촉진요인 정리

트랜스펙션 시약과 장비란 무엇이며, 왜 필요한가?

트랜스펙션 시약과 장비는 세포에 유전 물질을 도입하는 신뢰할 수 있고 효율적인 방법을 제공함으로써 유전자 연구를 촉진합니다. 이러한 툴을 통해 연구자들은 유전자 기능 및 조절을 연구하고, 질병을 모델링하고, 유전자 기반 치료법을 개발할 수 있습니다. 고급 형질전환 시약은 형질전환 효율을 개선하고 세포 독성을 감소시키며, 더 크고 복잡한 핵산을 전달할 수 있도록 개발되었습니다. 예를 들어 전기 천공 장비는 전기 펄스를 사용하여 세포막에 일시적인 구멍을 뚫어 핵산이 고효율로 세포 내로 들어갈 수 있도록 합니다. 이러한 시약과 장비는 주입 과정을 최적화함으로써 정확하고 재현성 있는 실험을 용이하게 하고 과학적 발견과 혁신적인 치료법 개발을 가속화합니다.

트랜스펙션 시약 및 장비에 대한 수요가 증가하는 이유는 무엇인가?

트랜스펙션 시약 및 장비에 대한 수요는 몇 가지 중요한 요인으로 인해 증가하고 있습니다. 유전자 기능 규명 및 유전자 치료법 개발로 인한 유전자 및 유전체 연구 증가는 고급 형질전환 툴의 필요성을 촉진하고 있으며, CRISPR-Cas9 및 기타 유전자 편집 기술을 포함한 생명공학 기술의 발전은 성공적인 형질전환을 위해 효율적인 형질전환 방법을 필요로 합니다. 필요합니다. 개인맞춤형 의료와 표적치료에 대한 관심이 높아지면서 새로운 치료법을 개발하고 시험하기 위한 신뢰할 수 있는 트랜스펙션 시스템에 대한 수요도 증가하고 있습니다. 또한 생명공학 및 제약 산업의 성장과 R&D 자금 증가로 인해 트랜스펙션 시약 및 장비 시장의 성장을 지원하고 있습니다. 학술 및 산업 연구 분야에서 효율적이고 재현성이 높은 트랜스펙션 방법에 대한 요구도 트랜스펙션 방법의 보급을 촉진하고 있습니다.

트랜스펙션 시약 및 장비 시장의 성장을 가속하는 요인은 무엇인가?

트랜스펙션 시약 및 장비 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 유전자 연구와 유전자 치료제 개발에 대한 관심이 높아짐에 따라 이러한 연구를 촉진하기 위한 첨단 트랜스펙션 툴이 필요하게 되었습니다. 전달 방법 개선 및 세포 독성 감소와 같은 기술 발전으로 인해 트랜스펙션 시약 및 장비의 효율성과 신뢰성이 향상되어 채택을 촉진하고 있습니다. 생명공학 및 제약 부문의 확대와 연구 자금 증가는 시장 성장을 지원하고 있습니다. 맞춤형 의료의 부상과 표적 치료의 필요성도 효율적인 주입 시스템에 대한 수요를 촉진하고 있습니다. 또한 CRISPR-Cas9와 같은 유전자 편집 기술의 적용이 확대됨에 따라 신뢰할 수 있는 전달 방법이 필요해지면서 시장 성장을 더욱 촉진하고 있습니다. 유전성 질환 및 암에 대한 새로운 치료법 개발에 대한 강조는 의학 연구 및 치료법 개발의 발전에 있으며, 형질전환 시약 및 장비의 중요성을 강조하고 있습니다.

조사 대상 기업의 예(주목 42사)

• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Life Technologies Corporation
• Lonza Group AG
• MilliporeSigma
• PolyPlus Battery Company(PPBC)
• Promega Corporation
• Qiagen NV
• SignaGen Laboratories
• Thermo Fisher Scientific, Inc.

목차

제1장 조사 방법

제2장 개요

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 세계 시장의 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 기타 유럽
• 아시아태평양
• 기타 지역

제4장 경쟁

영문목차

Global Transfection Reagents and Equipment Market to Reach US$1.8 Billion by 2030

The global market for Transfection Reagents and Equipment estimated at US$1.2 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Transfection Reagents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Transfection Equipment segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$324.1 Million While China is Forecast to Grow at 5.7% CAGR

The Transfection Reagents and Equipment market in the U.S. is estimated at US$324.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$282.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.3% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Transfection Reagents and Equipment Market - Key Trends & Drivers Summarized

What are Transfection Reagents and Equipment and Why are They Essential?

Transfection Reagents and Equipment are crucial tools used in molecular biology and genetic research to introduce nucleic acids (DNA or RNA) into cells. These tools are essential for various applications, including gene expression studies, protein production, and the development of genetically modified organisms. Transfection reagents, such as lipids, polymers, and electroporation solutions, facilitate the delivery of nucleic acids into cells by promoting their uptake and expression. Transfection equipment, including electroporators and microinjectors, provides the necessary technology to achieve efficient and reliable transfection. These tools are fundamental for advancing our understanding of gene function, disease mechanisms, and the development of novel therapeutics.

How Do Transfection Reagents and Equipment Enhance Genetic Research?

Transfection Reagents and Equipment enhance genetic research by providing reliable and efficient methods for introducing genetic material into cells. These tools enable researchers to study gene function and regulation, model diseases, and develop gene-based therapies. Advanced transfection reagents have been developed to improve transfection efficiency, reduce cytotoxicity, and enable the delivery of large or complex nucleic acids. Electroporation equipment, for instance, uses electrical pulses to create temporary pores in cell membranes, allowing nucleic acids to enter cells with high efficiency. By optimizing the transfection process, these reagents and equipment facilitate accurate and reproducible experiments, accelerating scientific discoveries and the development of innovative treatments.

Why is the Demand for Transfection Reagents and Equipment Increasing?

The demand for Transfection Reagents and Equipment is increasing due to several critical factors. The rise in genetic and genomic research, driven by the growing understanding of gene functions and the development of gene therapies, fuels the need for advanced transfection tools. Advances in biotechnology, including CRISPR-Cas9 and other gene-editing technologies, require efficient transfection methods for successful implementation. The increasing focus on personalized medicine and targeted therapies also drives the demand for reliable transfection systems to develop and test new treatments. Additionally, the growth of the biotechnology and pharmaceutical industries, along with increased funding for research and development, supports the expanding market for transfection reagents and equipment. The need for efficient and reproducible transfection methods in academic and industrial research further contributes to their widespread adoption.

What Factors are Driving the Growth of the Transfection Reagents and Equipment Market?

The growth in the Transfection Reagents and Equipment market is driven by several factors. The increasing focus on genetic research and the development of gene therapies necessitate advanced transfection tools to facilitate these studies. Technological advancements in transfection reagents and equipment, such as improved delivery methods and reduced cytotoxicity, enhance their efficiency and reliability, driving their adoption. The expansion of the biotechnology and pharmaceutical sectors, coupled with increased research funding, supports market growth. The rise of personalized medicine and the need for targeted therapies also propel the demand for efficient transfection systems. Additionally, the growing application of gene editing technologies like CRISPR-Cas9 requires reliable transfection methods, further boosting market growth. The emphasis on developing novel treatments for genetic disorders and cancers underscores the importance of transfection reagents and equipment in advancing medical research and therapeutic development.

Select Competitors (Total 42 Featured) -

• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Life Technologies Corporation
• Lonza Group AG
• MilliporeSigma
• PolyPlus Battery Company (PPBC)
• Promega Corporation
• Qiagen NV
• SignaGen Laboratories
• Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Transfection Reagents and Equipment - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Gene Therapy and Genetic Research
  • Technological Innovations in Transfection Methods
  • Expansion of Biotechnology and Pharmaceutical Industries
  • Increasing Investment in Cancer Research and Immunotherapy
  • Regulatory Approvals and Advancements in Clinical Applications
  • Growing Adoption of High-Throughput Screening
  • Market Demand for Efficient and Reliable Reagents
  • Impact of Personalized Medicine on Transfection Techniques
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Gene Expression Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Gene Expression Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Gene Expression Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Protein Production by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Transgenic Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Transgenic Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Transgenic Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Therapeutic Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Transfection Reagents and Equipment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Transfection Reagents and Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Transfection Reagents and Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Electroporation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Electroporation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Electroporation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Liposomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Particle Bombardment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Particle Bombardment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: World 16-Year Perspective for Particle Bombardment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: World 16-Year Perspective for Microinjection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Adenoviral Vectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Adenoviral Vectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: World 16-Year Perspective for Adenoviral Vectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Calcium Phosphate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Calcium Phosphate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: World 16-Year Perspective for Calcium Phosphate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: World 16-Year Perspective for Other Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: USA 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
• JAPAN
  • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
• CHINA
  • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 76: China 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 79: China 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 82: China 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
• EUROPE
  • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Transfection Reagents and Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Transfection Reagents and Equipment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 94: Europe 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
• FRANCE
  • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 97: France 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 100: France 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 103: France 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
• GERMANY
  • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 109: Germany 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 112: Germany 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 118: Italy 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 121: Italy 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 127: UK 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 130: UK 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Rest of World Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 151: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Rest of World Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 154: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
  • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Rest of World Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 157: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030

IV. COMPETITION